Clinical Trial: Venetoclax combined with cytarabine for consolidation therapy after induction in AML patients: A prospective, single-arm, multicenter, exploratory clinical study (China)

China, Sept. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Venetoclax combined with cytarabine for consolidation therapy after induction in AML patients: A prospective, single-arm, multicenter, exploratory clinical study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131945

Registration Time: 2026/09/08

Type: Interventional study

Primary Sponsor: Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336096

Published by HT Digital Content Services with permission from Health Daily Digest....